Phathom Pharmaceuticals Inc (PHAT) financials · rev $175.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Phathom Pharmaceuticals Inc (PHAT) rev $175.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $175.1M | $55.3M |
| Cost of Revenue | $22.6M | $7.97M |
| Gross Profit | $152.5M | $47.3M |
| Operating Income | -$160.0M | -$277.5M |
| Net Income | -$221.2M | -$334.3M |
| EPS (Diluted) | -$3.03 | -$5.29 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $259.1M | $378.3M |
| Current Assets | $229.0M | $360.1M |
| Cash & Equivalents | $130.0M | $297.3M |
| Inventory | $5.52M | $3.21M |
| PP&E | $1.06M | $1.48M |
| Total Liabilities | $697.3M | $631.9M |
| Current Liabilities | $132.0M | $85.7M |
| Short-term Debt | N/A | N/A |
| Long-term Debt | $209.1M | $201.4M |
| Total Debt | $209.1M† | $201.4M† |
| Shareholders' Equity | -$438.2M | -$253.6M |
| Retained Earnings | -$1.48B | -$1.26B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$166.8M | -$266.8M |
| CapEx | $229.0K | $135.0K |
| Investing Cash Flow | -$229.0K | -$135.0K |
| Financing Cash Flow | -$288.0K | $182.8M |
| Net Change in Cash | -$167.3M | -$84.1M |
| Free Cash Flow | -$167.0M | -$266.9M |
FAQ
What is PHAT P/E and revenue?
Phathom Pharmaceuticals Inc (PHAT) rev $175.1M.
What is PHAT revenue?
Phathom Pharmaceuticals Inc last cached revenue is $175.1M (FY2025).
Is PHAT profitable?
Phathom Pharmaceuticals Inc last cached net income is -$221.2M (FY2025).
What are PHAT total assets?
Phathom Pharmaceuticals Inc last cached total assets are $259.1M (FY2025).
What is PHAT free cash flow?
Phathom Pharmaceuticals Inc last cached free cash flow is -$167.0M (FY2025).
Not investment advice. Cached statements, not a live tape.